The role of omega-3 derived resolvins in arthritis

Current Opinion in Pharmacology

Volumn 13, Issue 3, 2013, Pages 476-481

  Norling, Lucy V ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AGENTS ACTING ON THE EYE; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; FISH OIL; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; RESOLVIN DERIVATIVE; RX 10045; TRIHYDROXYDOCOSAHEXAENOIC ACID; UNCLASSIFIED DRUG;

ANALGESIA; ATHEROSCLEROSIS; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRY EYE; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID SYNTHESIS; HUMAN; IN VIVO STUDY; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; PERIODONTITIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; TREATMENT RESPONSE;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 84879115613     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.02.003     Document Type: Review

References (30)

1. A.P. Simopoulos Omega-3 fatty acids in inflammation and autoimmune diseases J Am Coll Nutr 21 2002 495 505
2. P.C. Calder Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis Proc Nutr Soc 67 2008 409 418
3. R.J. Goldberg, and J. Katz A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain Pain 129 2007 210 223
4. R. De Caterina n-3 fatty acids in cardiovascular disease N Engl J Med 364 2011 2439 2450
5. R.J. Flower, and M. Perretti Controlling inflammation: a fat chance? J Exp Med 201 2005 671 674
6. L.V. Norling, and C.N. Serhan Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination J Intern Med 268 2010 15 24
7. D.W. Gilroy, T. Lawrence, M. Perretti, and A.G. Rossi Inflammatory resolution: new opportunities for drug discovery Nat Rev Drug Discov 3 2004 401 416
8. M. Spite, L.V. Norling, L. Summers, R. Yang, D. Cooper, N.A. Petasis, R.J. Flower, M. Perretti, and C.N. Serhan Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
9. Y.-P. Sun, S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S.P. Colgan, N.A. Petasis, and C.N. Serhan Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties and enzymatic inactivation J Biol Chem 282 2007 9323 9334
10. E. Mas, K.D. Croft, P. Zahra, A. Barden, and T.A. Mori Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation Clin Chem 58 2012 1476 1484
11. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem Rev 111 2011 5922 5943
12. M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J Exp Med 201 2005 713 722
13. Y. Birnbaum, Y. Ye, Y. Lin, S.Y. Freeberg, S.P. Nishi, J.D. Martinez, M.H. Huang, B.F. Uretsky, and J.R. Perez-Polo Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat Circulation 114 2006 929 935
14. A.J. Merched, K. Ko, K.H. Gotlinger, C.N. Serhan, and L. Chan Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators FASEB J 22 2008 3595 3606
15. H. Hasturk, A. Kantarci, E. Goguet-Surmenian, A. Blackwood, C. Andry, C.N. Serhan, and T.E. Van Dyke Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo J Immunol 179 2007 7021 7029
16. L.V. Norling, M. Spite, R. Yang, R.J. Flower, M. Perretti, and C.N. Serhan Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing J Immunol 186 2011 5543 5547
17. R.V. Bessa-Nogueira, B.C. Vasconcelos, A.P. Duarte, P.S. Goes, and T.P. Bezerra Targeted assessment of the temporomandibular joint in patients with rheumatoid arthritis J Oral Maxillofac Surg 66 2008 1804 1811
18. T. Ueno, T. Kagawa, M. Kanou, N. Ishida, T. Fujii, J. Fukunaga, N. Mizukawa, and T. Sugahara Pathology of the temporomandibular joint of patients with rheumatoid arthritis - case reports of secondary amyloidosis and macrophage populations J Craniomaxillofac Surg 31 2003 252 256
19. G.W. Gynther, A.B. Holmlund, F.P. Reinholt, and S. Lindblad Temporomandibular joint involvement in generalized osteoarthritis and rheumatoid arthritis: a clinical, arthroscopic, histologic, and immunohistochemical study Int J Oral Maxillofac Surg 26 1997 10 16
20. J.F. Lima-Garcia, R.C. Dutra, K. da Silva, E.M. Motta, M.M. Campos, and J.B. Calixto The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats Br J Pharmacol 164 2011 278 293
21. C.K. Park, Z.Z. Xu, T. Liu, N. Lu, C.N. Serhan, and R.R. Ji Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1 J Neurosci 31 2011 18433 18438
22. H.L. Wright, R.J. Moots, R.C. Bucknall, and S.W. Edwards Neutrophil function in inflammation and inflammatory diseases Rheumatology 49 2010 1618 1631
23. P. de Pablo, I.L. Chapple, C.D. Buckley, and T. Dietrich Periodontitis in systemic rheumatic diseases Nat Rev: Rheumatol 5 2009 218 224
24. C.M. Queiroz-Junior, M.F. Madeira, F.M. Coelho, V.V. Costa, R.L. Bessoni, L.F. Sousa, G.P. Garlet, G. Souza Dda, M.M. Teixeira, and T.A. Silva Experimental arthritis triggers periodontal disease in mice: involvement of TNF-alpha and the oral microbiota J Immunol 187 2011 3821 3830
25. G. Kronke, J. Katzenbeisser, S. Uderhardt, M.M. Zaiss, C. Scholtysek, G. Schabbauer, A. Zarbock, M.I. Koenders, R. Axmann, and J. Zwerina 12/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis J Immunol 183 2009 3383 3389
26. N. Dufton, R. Hannon, V. Brancaleone, J. Dalli, H.B. Patel, M. Gray, F. D'Acquisto, J.C. Buckingham, M. Perretti, and R.J. Flower Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation J Immunol 184 2010 2611 2619
27. V.A. Blaho, Y. Zhang, J.M. Hughes-Hanks, and C.R. Brown 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis J Immunol 186 2011 3076 3084
28. K.R. Gheorghe, M. Korotkova, A.I. Catrina, L. Backman, E. af Klint, H.E. Claesson, O. Radmark, and P.J. Jakobsson Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids Arthritis Res Ther 11 2009 R83
29. A. Hashimoto, I. Hayashi, Y. Murakami, Y. Sato, H. Kitasato, R. Matsushita, N. Iizuka, K. Urabe, M. Itoman, and S. Hirohata Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis J Rheumatol 34 2007 2144 2153
30. M. Giera, A. Ioan-Facsinay, R. Toes, F. Gao, J. Dalli, A.M. Deelder, C.N. Serhan, and O.A. Mayboroda Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS Biochim Biophys Acta 1821 2012 1415 1424